BIO KEY INTERNATIONAL INC
Built from the SEC filing index the day the filing landed. The figures below are the issuer's own from Form D; AltStreet's analysis, sponsor link and data flags follow when the entity is enriched.
Raised
$548K
Investors
1
Min Invest
$547,730
Is this your company or fund? Claim this page free, or verify it and carry the Verified Issuer mark.
What this filing shows
·Every sentence is a value as filed on SEC Form D
BIO KEY INTERNATIONAL INC is a Delaware corporation that first filed a Form D on November 19, 2014 and most recently amended it on January 4, 2024 in the Other Technology industry group. The offering claims Rule 506(b) and covers equity. BIO KEY INTERNATIONAL INC reported $547,730 sold from 1 investor of a $547,730 total offering as of the Form D filed January 4, 2024. The offering relies on Rule 506(b), which permits sales to accredited investors and to no more than 35 non-accredited investors who meet a sophistication standard, and prohibits general solicitation. The filing reports no non-accredited investors. The minimum investment accepted from an outside investor is $547,730. The Form D names Maxim Group LLC (CRD 120708) as the recipient of sales compensation soliciting in NY. Sales commissions are reported as $37,341 and finders' fees as $0. Form D allows these to be estimates. The issuer's address of record is 101 Crawfords Corner Rd, Suite 4116, Holmdel, NJ 07733.
EDGAR Filing Data
Form D — Primary Source
View on SEC.govFilings on Record
Every filing AltStreet's ledger holds for this CIK, newest first. Each opens the SEC archive folder.
In the Terminal
Filing events
1
latest Jan 4, 2024
Critical / warning
0 / 0
0 watch · 1 info
Statements extracted
0
none on file
NAV prints
0
none on file
Offering chains
3
closed, dark
Latest event New filer · Jan 4, 2024
SEC.govInvestor
- 1 filing event with values and deltas, latest 2024-01-04, and alerts on the next one
- 3 offering timelines: velocity, share raised, first-sale lag, stalled flags
Pro
- This issuer against its cohort: rank by velocity and share raised among offerings filed the same quarter
- The same events, statements and NAV moves across every issuer, screenable, with unlimited watches and CSV
Counts and dates above are the free record. The values, the series and the comparisons are the seat. Loading your view…
Related Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
Item 3 changed on the Form D filed 2024-01-04: 3 related persons added and 5 removed against the filing of 2019-07-25; 8 now listed. The names are in the Terminal feed.
Michael DePasquale
Executive Officer, Director · HOLMDEL, NJ
Cecilia Welch
Executive Officer · HOLMDEL, NJ
Jim Sullivan
Executive Officer · HOLMDEL, NJ
Mira LaCous
Executive Officer · HOLMDEL, NJ
Emmanuel Alia
Director · HOLMDEL, NJ
Cameron Williams
Director · HOLMDEL, NJ
Robert Michel
Director · HOLMDEL, NJ
Kwok Fong Wong
Director · HOLMDEL, NJ
Placement Agents and Sales Compensation (Form D)
Who the issuer reported paying to sell the securities (Form D Item 12), with the FINRA registration number the filer gave. Source: SEC.gov.
Maxim Group LLCCRD 120708 on BrokerCheck
NEW YORK, NY · Soliciting in NY
Questions About BIO KEY INTERNATIONAL INC
Each answer is built from the values on the SEC filing and the AltStreet ledger, not from the issuer's marketing.
What is BIO KEY INTERNATIONAL INC?
BIO KEY INTERNATIONAL INC is a Delaware corporation that filed a Form D with the SEC on January 4, 2024 in the Other Technology industry group. The filing claims Rule 506(b) for an offering of equity.
Is BIO KEY INTERNATIONAL INC legit?
AltStreet does not rate legitimacy; it reports the public record. BIO KEY INTERNATIONAL INC filed a Form D with the SEC on January 4, 2024 claiming Rule 506(b). A Form D is a notice of an exempt offering, not a review or approval of it. The newest notice reports $547,730 sold to 1 investor. AltStreet's enforcement record (SEC, FINRA and state actions) shows no action naming the issuer as of today. Before investing, confirm the filing on EDGAR, check the seller's registration on FINRA BrokerCheck, and read the offering documents, which a Form D does not include.
Is BIO KEY INTERNATIONAL INC registered with or approved by the SEC?
No. A Form D is a notice that an issuer is selling securities under an exemption from registration, and the SEC does not review, approve, or pass on the merits of the offering. The filing shows that BIO KEY INTERNATIONAL INC claimed Rule 506(b) and disclosed the items the form requires, such as the amount sold, the minimum investment, related persons, and anyone paid to sell the securities. It does not verify the issuer's claims or its business.
How much has BIO KEY INTERNATIONAL INC raised?
BIO KEY INTERNATIONAL INC reported $547,730 sold from 1 investor of a $547,730 total offering as of the Form D filed January 4, 2024.
Who can invest in BIO KEY INTERNATIONAL INC?
The offering relies on Rule 506(b), which permits sales to accredited investors and to no more than 35 non-accredited investors who meet a sophistication standard, and prohibits general solicitation. The filing reports no non-accredited investors. The minimum investment accepted from an outside investor is $547,730.
What is the minimum investment in BIO KEY INTERNATIONAL INC?
The Form D lists $547,730 as the minimum investment accepted from any outside investor as of January 4, 2024. Issuers can waive their own minimums, and the figure does not include fees.
Who is selling BIO KEY INTERNATIONAL INC and how are they paid?
The Form D names Maxim Group LLC (CRD 120708) as the recipient of sales compensation soliciting in NY. Sales commissions are reported as $37,341 and finders' fees as $0. Form D allows these to be estimates.
Who is behind BIO KEY INTERNATIONAL INC?
The Form D lists 8 related persons: Michael DePasquale, executive officer, director; Cecilia Welch, executive officer; Jim Sullivan, executive officer; Mira LaCous, executive officer; Emmanuel Alia, director; Cameron Williams, director; Robert Michel, director; Kwok Fong Wong, director. Form D Item 3 requires executive officers, directors, and promoters of the issuer to be listed.
Where is BIO KEY INTERNATIONAL INC located?
The issuer's address on its SEC filings is 101 Crawfords Corner Rd, Suite 4116, Holmdel, NJ 07733. Its phone number of record is 7323591100. It is organized under the laws of Delaware.
How long is the BIO KEY INTERNATIONAL INC offering open?
The issuer indicated that the offering is not intended to last more than one year. An issuer must amend its Form D annually while a continuing offering stays open; 1 amendment is on record for this CIK.
What is BIO KEY INTERNATIONAL INC's revenue?
The issuer declined to disclose its revenue range on the Form D, which the form permits.

Is this your company or fund?
Free claim: add your contact details, website, team and a description to this page. The filed facts stay as filed.
Verified Issuer, $480 a year: AltStreet checks the identity of your company and the authority of the person claiming it against your filings, confirms your contact details on a stated date and again at each renewal, and marks the page so people researching you find a current, attributed profile beside the public filing record. It is not a review of any offering.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.
